TSX:WEED (Canopy Growth)
About WEED
Canopy Growth Corp. engages in the production and sale of medical cannabis. The firm operates through the following segments: Global Cannabis and Other Consumer Products. The Global Cannabis segment encompasses the production, distribution and sale of a diverse range of cannabis and cannabinoid-based consumer products in Canada and internationally pursuant to applicable international and domestic legislation, regulations and permits. The Other Consumer Products segment encompasses the production, distribution and sale of consumer products by Storz & Bickel, This Works, BioSteel, and other ancillary revenue sources. It focuses on the treatment of chronic pain, seizures, muscle spasms, nausea, and loss of appetite. The company was founded by Bruce Linton on August 5, 2009 and is headquartered in Smith Falls, Canada.
Canopy Growth (TSX: WEED) Latest News
Investing
Canopy Growth Corp.: Is it Safe to Buy After Mettrum’s Banned Pesticide Incident?
Investing
Canopy Growth Corp.: Does This Stock Belong in Your Portfolio?
Dividend Stocks
How to Judge Portfolio Liquidity
Investing
3 Reasons to Think Twice About New Cannabis ETF
Investing
Canopy Growth Corp.: Is it Wise to Buy This Stock Today?
Dividend Stocks
Investors: Buy This 7.9% Yielder Instead of Canopy Growth Corp.
Investing
Can Aphria Inc. Challenge Canopy Growth Corp.’s Dope Dominance?
Investing
Why Aphria Inc. Is a Much Better Long-Term Play Than Canopy Growth Corp.
Investing
Could Aurora Cannabis Inc. Steal the Euphoria From Canopy Growth Corp. and Aphria Inc.?
Investing
Canopy Growth Corp. Could Crash Over Use of Banned Pesticides
Investing
Canopy Growth Corp.: Is This WEED About to Bloom?